Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,166,819 papers from all fields of science
Search
Sign In
Create Free Account
P2RY12 gene
Known as:
PURINORECEPTOR P2Y12
, P2RY12
, HORK3
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
LPAR6 gene
P2RY1 gene
P2RY10 gene
P2RY11 gene
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Implications of the PEGASUS-TIMI 54 trial for US clinical practice
S. Bradley
,
G. Hess
,
+6 authors
T. Maddox
Open Heart
2017
Corpus ID: 3484905
Objectives This study aims to determine the proportion of real-world patients with myocardial infarction (MI) who would have been…
Expand
2017
2017
Expression site of P2RY12 in residential microglial cells in astrocytomas correlates with M1 and M2 marker expression and tumor grade
Changbin Zhu
,
J. Kros
,
M. M. van der Weiden
,
P. Zheng
,
Caroline Cheng
,
D. Mustafa
Acta Neuropathologica Communications
2017
Corpus ID: 256406337
The role of resident microglial cells in the pathogenesis and progression of glial tumors is still obscure mainly due to a lack…
Expand
2017
2017
The platelet P 2 receptors in inflammation
M. Cattaneo
2017
Corpus ID: 1835479
In addition to their well characterized and established role in haemostasis and thrombosis, platelets contribute to the…
Expand
2016
2016
Platelet reactivity after administration of third generation P2Y12-antagonists does not depend on body weight in contrast to clopidogrel
C. Olivier
,
Katharina Schnabel
,
+4 authors
P. Diehl
Journal of Thrombosis and Thrombolysis
2016
Corpus ID: 11570501
The current standard of antiplatelet therapy for patients with myocardial infarction (MI) includes the P2Y12-receptor antagonist…
Expand
2016
2016
Prasugrel, a Platelet P2Y12 Receptor Antagonist, Improves Abnormal Gait in a Novel Murine Model of Thrombotic Hindlimb Ischemia
Kousaku Ohno
,
A. Tomizawa
,
M. Mizuno
,
J. Jakubowski
,
A. Sugidachi
Journal of the American Heart Association…
2016
Corpus ID: 1497437
Background The efficacy of P2Y12 inhibition for the prevention of cardiovascular events in patients with peripheral arterial…
Expand
2016
2016
Evaluation of clopidogrel response variability and identification of the CYP2C19 polymorphism in Mexican patients.
M. E. Viveros
,
C. Areán
,
+6 authors
N. García
Archivos de Cardiología de México
2016
Corpus ID: 11087467
Review
2014
Review
2014
Significance of antiplatelet therapy in emergency myocardial infarction treatment
Anna Komosa
,
M. Lesiak
,
Andrzej Siniawski
,
T. Mularek-Kubzdela
,
S. Grajek
Postepy w kardiologii interwencyjnej = Advances…
2014
Corpus ID: 9454464
Antiplatelet drugs play a crucial role in the treatment of patients with myocardial infarction, particularly in association with…
Expand
2014
2014
Association Between the P2RY12 Receptor Gene Polymorphism and Aspirin Resistance in Patients with Coronary Artery Disease
Ludmila Karazhanova
,
Sholpan Zhukusheva
,
A. Akilzhanova
Central Asian Journal of Global Health
2014
Corpus ID: 44102834
Introduction Platelet activation and aggregation are key elements in the development of coronary atherosclerosis. Recent studies…
Expand
2011
2011
12 Relationship between proportions of P2Y12 inhibited platelets and aggregation in vitro
Thomas Hoefer
,
N. Kirkby
,
N. Kirkby
,
Timothy D. Warner
Heart
2011
Corpus ID: 72910134
Inhibition of platelet aggregation following aspirin ingestion is thought to be overcome by the presence of a small minority of…
Expand
2008
2008
Carba‐nucleosides as Potent Antagonists of the Adenosine 5′‐Diphosphate (ADP) Purinergic Receptor (P2Y12) on Human Platelets
Hong Ye
,
Cailin Chen
,
+4 authors
B. Maryanoff
ChemMedChem
2008
Corpus ID: 9606196
Whereas the activation and aggregation of blood platelets are crucial to normal hemostasis, this ensemble is also a key factor in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE